MicroRNAs in the DNA damage/repair network and cancer

International Journal of Genomics

Volumn 2014, Issue , 2014, Pages

  Tessitore, Alessandra ^a   Cicciarelli, Germana ^a   Del Vecchio, Filippo ^a   Gaggiano, Agata ^a   Verzella, Daniela ^a   Fischietti, Mariafausta ^a   Vecchiotti, Davide ^a   Capece, Daria ^a   Zazzeroni, Francesca ^a   Alesse, Edoardo ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN P53;

BIOGENESIS; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; DNA DAMAGE; DNA REPAIR; GENE CONTROL; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; S PHASE CELL CYCLE CHECKPOINT; UPREGULATION;

EID: 84896842872     PISSN: 2314436X     EISSN: 23144378     Source Type: Journal    
DOI: 10.1155/2014/820248     Document Type: Review

References (105)

1. Jackson S. P., Bartek J., The DNA-damage response in human biology and disease. Nature 2009 461 7267 1071 1078 2-s2.0-70350504453 10.1038/nature08467
2. Ward I., Chen J., Early events in the DNA damage response. Current Topics in Developmental Biology 2004 63 1 35 10.1016/S0070-2153(04)63001-8
3. Vigneron A., Cherier J., Barré B., Gamelin E., Coqueret O., The cell cycle inhibitor p21-waf1 binds to the myc and cdc25a promoters upon DNA damage and induces transcriptional repression. Journal of Biological Chemistry 2006 281 46 34742 34750 2-s2.0-33845939121 10.1074/jbc.M602492200
4. Ciccia A., Elledge S. J., The DNA damage response: making it safe to play with knives. Molecular Cell 2010 40 2 179 204 2-s2.0-78649336706 10.1016/j.molcel.2010.09.019
5. Matsuoka S., Ballif B. A., Smogorzewska A., McDonald E. R. III, Hurov K. E., Luo J., Bakalarski C. E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S. P., Elledge S. J., ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007 316 5828 1160 1166 2-s2.0-34249947699 10.1126/science.1140321
6. Kastan M. B., Lim D.-S., The many substrates and functions of ATM. Nature Reviews Molecular Cell Biology 2000 1 3 179 186 2-s2.0-0034576494
7. Abraham R. T., Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes and Development 2001 15 17 2177 2196 2-s2.0-0035449355 10.1101/gad.914401
8. Shiloh Y., ATM and ATR: networking cellular responses to DNA damage. Current Opinion in Genetics and Development 2001 11 1 71 77 2-s2.0-0035253615 10.1016/S0959-437X(00)00159-3
9. Bartek J., Lukas J., Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003 3 5 421 429 2-s2.0-0038418869 10.1016/S1535-6108(03) 00110-7
10. Falck J., Mailand N., Syljuåsen R. G., Bartek J., Lukas J., The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001 410 6830 842 847 2-s2.0-0035848819 10.1038/35071124
11. Donzelli M., Draetta G. F., Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Reports 2003 4 7 671 677 2-s2.0-0043066731 10.1038/sj.embor.embor887
12. Rudolph J., Cdc25 phosphatases: structure, specificity, and mechanism. Biochemistry 2007 46 12 3595 3604 2-s2.0-33947646873 10.1021/bi700026j
13. Manke I. A., Nguyen A., Lim D., Stewart M. Q., Elia A. E. H., Yaffe M. B., MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G 2/M transition and S phase progression in response to UV irradiation. Molecular Cell 2005 17 1 37 48 2-s2.0-11344286593 10.1016/j.molcel.2004.11.021
14. Raman M., Earnest S., Zhang K., Zhao Y., Cobb M. H., TAO kinases mediate activation of p38 in response to DNA damage. EMBO Journal 2007 26 8 2005 2014 2-s2.0-34247269029 10.1038/sj.emboj.7601668
15. Reinhardt H. C., Aslanian A. S., Lees J. A., Yaffe M. B., p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007 11 2 175 189 2-s2.0-33846821915 10.1016/j.ccr.2006.11.024
16. Reinhardt H. C., Hasskamp P., Schmedding I., Morandell S., van Vugt M. A. T. M., Wang X., Linding R., Ong S.-E., Weaver D., Carr S. A., Yaffe M. B., DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Molecular Cell 2010 40 1 34 49 2-s2.0-77957361354 10.1016/j.molcel.2010.09.018
17. Reinhardt H. C., Yaffe M. B., Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Current Opinion in Cell Biology 2009 21 2 245 255 2-s2.0-63749131243 10.1016/j.ceb.2009.01.018
18. Boucas J., Riabinska A., Jokic M., Herter-Sprie G. S., Chen S., Höpker K., Reinhardt H. C., Posttranscriptional regulation of gene expression-adding another layer of complexity to the DNA damage response. Frontiers in Genetics 2012 3 article 159 10.3389/fgene.2012.00159
19. Bartek J., Lukas J., DNA damage checkpoints: from initiation to recovery or adaptation. Current Opinion in Cell Biology 2007 19 2 238 245 2-s2.0-33847737716 10.1016/j.ceb.2007.02.009
20. Natarajan A. T., Palitti F., DNA repair and chromosomal alterations. Mutation Research 2008 657 1 3 7 2-s2.0-56349162470 10.1016/j.mrgentox.2008.08. 017
21. Acharya S., Foster P. L., Brooks P., Fishel R., The coordinated functions of the E. coli MutS and MutL proteins in mismatch repair. Molecular Cell 2003 12 1 233 246 2-s2.0-0041669372 10.1016/S1097-2765(03)00219-3
22. Kolodner R. D., Mendillo M. M., Putnam C. D., Coupling distant sites in DNA during DNA mismatch repair. Proceedings of the National Academy of Sciences of the United States of America 2007 104 32 12953 12954 2-s2.0-34548783162 10.1073/pnas.0705698104
23. Hoeijmakers J. H. J., Genome maintenance mechanisms for preventing cancer. Nature 2001 411 6835 366 374 2-s2.0-0035902108 10.1038/35077232
24. Lieber M. R., The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annual Review of Biochemistry 2010 79 181 211 2-s2.0-77953229115 10.1146/annurev.biochem.052308.093131
25. Shibata A., Conrad S., Birraux J., Geuting V., Barton O., Ismail A., Kakarougkas A., Meek K., Taucher-Scholz G., Löbrich M., Jeggo P. A., Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO Journal 2011 30 6 1079 1092 2-s2.0-79952762235 10.1038/emboj.2011.27
26. Wouters M. D., Van Gent D. C., Hoeijmakers J. H. J., Pothof J., MicroRNAs, the DNA damage response and cancer. Mutation Research 2011 717 1-2 54 66 2-s2.0-82755194807 10.1016/j.mrfmmm.2011.03.012
27. Olivier M., Hollstein M., Hainaut P., TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harbor Perspectives in Biology 2010 2 1 2-s2.0-77955363995 a001008 10.1101/cshperspect.a001008
28. Rieger K. E., Chu G., Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. Nucleic Acids Research 2004 32 16 4786 4803 2-s2.0-4444236147 10.1093/nar/gkh783
29. Reinhardt H. C., Cannell I. G., Morandell S., Yaffe M. B., Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response? Cell Cycle 2011 10 1 23 27 2-s2.0-78650817044 10.4161/cc.10.14351
30. Rockx D. A., Mason R., Van Hoffen A., Barton M. C., Citterio E., Bregman D. B., Van Zeeland A. A., Vrieling H., Mullenders L. H. F., UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II. Proceedings of the National Academy of Sciences of the United States of America 2000 97 19 10503 10508 2-s2.0-0034641753
31. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T., Identification of novel genes coding for small expressed RNAs. Science 2001 294 5543 853 858 2-s2.0-0035955374 10.1126/science.1064921
32. Nakahara K., Carthew R. W., Expanding roles for miRNAs and siRNAs in cell regulation. Current Opinion in Cell Biology 2004 16 2 127 133 2-s2.0-2942620391 10.1016/j.ceb.2004.02.006
33. Ichimura A., Ruike Y., Terasawa K., Tsujimoto G., miRNAs and regulation of cell signaling. FEBS Journal 2011 278 10 1610 1618 2-s2.0-79955608010 10.1111/j.1742-4658.2011.08087.x
34. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
35. Wan G., Mathur R., Hu X., Zhang X., Lu X., miRNA response to DNA damage. Trends in Biochemical Sciences 2011 36 9 478 484 2-s2.0-80052391165 10.1016/j.tibs.2011.06.002
36. Kim Y., Kim V. N., Processing of intronic microRNAs. EMBO Journal 2007 26 3 775 783 2-s2.0-33846945735 10.1038/sj.emboj.7601512
37. Mulligan J. A., MicroRNA Expression, Detection and Therapeutic Strategies 2011 New York, NY, USA Nova Science DNA and RNA: Properties and Modifications, Functions and Interactions, Recombination and Applications
38. Lu J., Getz G., Miska E. A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B. L., Mak R. H., Ferrando A. A., Downing J. R., Jacks T., Horvitz H. R., Golub T. R., MicroRNA expression profiles classify human cancers. Nature 2005 435 7043 834 838 2-s2.0-20444460289 10.1038/nature03702
39. Hu H., Du L., Nagabayashi G., Seeger R. C., Gatti R. A., ATM is down-regulated by N-Myc-regulated microRNA-421. Proceedings of the National Academy of Sciences of the United States of America 2010 107 4 1506 1511 2-s2.0-76549127430 10.1073/pnas.0907763107
40. Ng W. L., Yan D., Zhang X., Mo Y.-Y., Wang Y., Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. DNA Repair 2010 9 11 1170 1175 2-s2.0-78049414216 10.1016/j.dnarep.2010. 08.007
41. Yan D., Ng W. L., Zhang X., Wang P., Zhang Z., Mo Y.-Y., Mao H., Hao C., Olson J. J., Curran W. J., Wang Y., Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 2010 5 7 e11397 2-s2.0-77958133262 10.1371/journal.pone.0011397
42. Song L., Lin C., Wu Z., Gong H., Zeng Y., Wu J., Li M., Li J., miR-18a impairs DNA damage response through downregulation of Ataxia telangiectasia mutated (ATM) kinase. PLoS One 2011 6 9 2-s2.0-80053194900 e2545 10.1371/journal.pone.0025454
43. Wu C. W., Dong Y. J., Liang Q. Y., He X. Q., Ng S. S. M., Chan F. K. L., Song J. J. Y., MicroRNA 18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. PLoS One 2013 8 2 e57036
44. Zhang X., Wan G., Berger F. G., He X., Lu X., The ATM kinase induces microRNA biogenesis in the DNA damage response. Molecular Cell 2011 41 4 371 383 2-s2.0-79951500251 10.1016/j.molcel.2011.01.020
45. Burma S., Chen B. P., Murphy M., Kurimasa A., Chen D. J., ATM phosphorylates histone H2AX in response to DNA double-strand breaks. Journal of Biological Chemistry 2001 276 45 42462 42467 2-s2.0-0035834693 10.1074/jbc.C100466200
46. Wang Y., Huang J.-W., Li M., Cavenee W. K., Mitchell P. S., Zhou X., Tewari M., Furnari F. B., Taniguchi T., MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Molecular Cancer Research 2011 9 8 1100 1111 2-s2.0-80051975920 10.1158/1541-7786.MCR-11-0007
47. Tsai Y.-S., Lin C.-S., Chiang S.-L., Lee C.-H., Lee K.-W., Ko Y.-C., Areca nut induces miR-23a and inhibits repair of DNA double-strand breaks by targeting FANCG. Toxicological Sciences 2011 123 2 480 490 2-s2.0-80053459622 10.1093/toxsci/kfr182
48. Chang L., Hu W., Ye C., Yao B., Song L., Wu X., Ding N., Wang J., Zhou G., miR-3928 activates ATR pathway by targeting Dicer. RNA Biology 2012 9 10 1247 1254 10.4161/rna.21821
49. Wang J., He J., Su F., Ding N., Hu W., Yao B., Wang W., Zhou G., Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition. Cell Death & Disease 2013 4 article e699 10.1038/cddis.2013.227
50. Chang T., Wentzel E., Kent O., Mendell J., Mullendore M., Lee K., Feldmann G., Yamakuchi M., Ferlito M., Lowenstein C. J., Arking D., Beer M. A., Maitra A., Ramachandran K., Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Molecular Cell 2007 26 5 745 752 2-s2.0-34249817549 10.1016/j.molcel.2007.05.010
51. Bommer G., Gerin I., Feng Y., Fearon E., Kuick R., Love R. E., Zhai Y., Giordano T. J., Qin Z. S., Moore B. B., MacDougald O. A., Cho K. R., Kaczorowski A. J., p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Current Biology 2007 17 15 1298 1307 2-s2.0-34547458550 10.1016/j.cub.2007.06. 068
52. Welch C., Chen Y., Stallings R. L., MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007 26 34 5017 5022 2-s2.0-34249812122 10.1038/sj.onc.1210293
53. Maki Y., Asano H., Toyooka S., Soh J., Kubo T., Katsui K., Ueno T., Shien K., Muraoka T., Tanaka N., Yamamoto H., Tsukuda K., Kishimoto T., Kanazawa S., Miyoshi S., MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells. Anticancer Reseach 2012 32 11 4871 4875
54. Josson S., Sung S.-Y., Lao K., Johnstone P. A. S., Radiation modulation of microRNA in prostate cancer cell lines. Prostate 2008 68 15 1599 1606 2-s2.0-55249113496 10.1002/pros.20827
55. Shin S., Cha H. J., Lee E.-M., Lee S.-J., Seo S.-K., Jin H.-O., Park I.-C., Jin Y.-W., An S., Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. International Journal of Oncology 2009 35 1 81 86 2-s2.0-67649445759 10.3892/ijo-00000315
56. Li Z., Branham W. S., Dial S. L., Wang Y., Guo L., Shi L., Chen T., Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxic carcinogen N-ethyl-N-nitrosourea. BMC Genomics 2010 11 1, article 609 2-s2.0-77958557351 10.1186/1471-2164-11-609
57. Saleh A. D., Savage J. E., Cao L., Soule B. P., Ly D., DeGraff W., Harris C. C., Mitchell J. B., Simone N. L., Cellular stress induced alterations in microrna let-7a and let-7b expression are dependent on p53. PLoS One 2011 6 10 2-s2.0-80054115192 e24429 10.1371/journal.pone.0024429
58. Lu X., Nguyen T.-A., Moon S.-H., Darlington Y., Sommer M., Donehower L. A., The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer and Metastasis Reviews 2008 27 2 123 135 2-s2.0-43049128122 10.1007/s10555-008-9127-x
59. Zhang X., Wan G., Mlotshwa S., Vance V., Berger F. G., Chen H., Lu X., Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Research 2010 70 18 7176 7186 2-s2.0-77956896318 10.1158/0008-5472.CAN-10-0697
60. Suh S.-S., Yoo J. Y., Nuovo G. J., Jeon Y.-J., Kim S., Lee T. J., Kim T., Bakacs A., Alder H., Kaur B., Aqeilan R. I., Pichiorri F., Croce C. M., MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America 2012 109 14 5316 5321 2-s2.0-84859470540 10.1073/pnas.1202465109
61. Dar A. A., Majid S., Rittsteuer C., de Semir D., Bezrookove V., Tong S., Nosrati M., Sagebiel R., Miller 3rd J. R., Kashani-Sabet M., The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. Journal of the National Cancer Institute 105 6 433 442 10.1093/jnci/djt003
62. Amir S., Ma A. H., Shi X. B., Xue L., Kung H. J., Devere White R. W., Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. PLoS One 2013 8 4 10.1371/journal.pone.0061064 e61064
63. Shi X.-B., Xue L., Ma A.-H., Tepper C. G., Kung H.-J., White R. W. D., MiR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 2011 71 5 538 549 2-s2.0-79951529658 10.1002/pros.21270
64. Avasarala S., Van Scoyk M., Wang J., Sechler M., Vandervest K., Brzezinski C., Weekes C., Edwards M. G., Arcaroli J., Davis R. E., Bikkavilli R. K., Winn R. A., hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative rolein non-small cell lung cancer cells via targeting MDM2expression. Biology Open 2013 2 675 685
65. Hoffman Y., Bublik D. R., Pilpel Y., Oren M., miR-661 downregulates both Mdm2 and Mdm4to activate p53. Cell Death and Differentiation 2014 21 2 302 330 10.1038/cdd.2013.146
66. Lanza G., Ferracin M., Gafà R., Veronese A., Spizzo R., Pichiorri F., Liu C.-G., Calin G. A., Croce C. M., Negrini M., mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Molecular Cancer 2007 6 article 54 2-s2.0-35748967324 10.1186/1476-4598-6-54
67. Hayashita Y., Osada H., Tatematsu Y., Yamada H., Yanagisawa K., Tomida S., Yatabe Y., Kawahara K., Sekido Y., Takahashi T., A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Research 2005 65 21 9628 9632 2-s2.0-27544495514 10.1158/0008-5472.CAN-05-2352
68. Sarver A. L., French A. J., Borralho P. M., Thayanithy V., Oberg A. L., Silverstein K. A. T., Morlan B. W., Riska S. M., Boardman L. A., Cunningham J. M., Subramanian S., Wang L., Smyrk T. C., Rodrigues C. M. P., Thibodeau S. N., Steer C. J., Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009 9 article 401 2-s2.0-71549125896 10.1186/1471-2407-9-401
69. Valeri N., Gasparini P., Fabbri M., Braconi C., Veronese A., Lovat F., Adair B., Vannini I., Fanini F., Bottoni A., Costinean S., Sandhu S. K., Nuovo G. J., Alder H., Gafa R., Calore F., Ferracin M., Lanza G., Volinia S., Negrini M., McIlhatton M. A., Amadori D., Fishel R., Croce C. M., Modulation of mismatch repair and genomic stability by miR-155. Proceedings of the National Academy of Sciences of the United States of America 2010 107 15 6982 6987 10.1073/pnas.1002472107
70. Valeri N., Gasparini P., Braconi C., Paone A., Lovat F., Fabbri M., Sumani K. M., Alder H., Amadori D., Patel T., Nuovo G. J., Fishel R., Croce C. M., MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proceedings of the National Academy of Sciences of the United States of America 2010 107 49 21098 21103 2-s2.0-78650500590 10.1073/pnas.1015541107
71. Yu Y., Wang Y., Ren X., Tsuyada A., Li A., Liu L. J., Wang S. E., Context-dependent bidirectional regulation of the mutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells. Molecular Cancer Research 2010 8 12 1633 1642 2-s2.0-78650423960 10.1158/1541-7786.MCR-10-0362
72. Massagué J., TGF- β signal transduction. Annual Review of Biochemistry 1998 67 753 791
73. Zhang Y. X., Yue Z., Wang P. Y., Li Y. J., Xin J. X., Pang M., Zheng Q. Y., Xie S. Y., Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth. Biomedicine & Pharmacotherapy 67 2 97 102 10.1016/j.biopha.2012.11.008
74. Oberg A. L., French A. J., Sarver A. L., Subramanian S., Morlan B. W., Riska S. M., Borralho P. M., Cunningham J. M., Boardman L. A., Wang L., Smyrk T. C., Asmann Y., Steer C. J., Thibodeau S. N., miRNA expression in colon polyps provides evidence for a Multihit model of colon cancer. PLoS One 2011 6 6 2-s2.0-79958270237 e20465 10.1371/journal.pone.0020465
75. Mueller A. C., Sun D., Dutta A., The miR-99 family regulates the DNA damage response through its target SNF2H. Oncogene 2013 32 9 1164 1172 2-s2.0-84859891015 10.1038/onc.2012.131
76. Mihailova V. T., Bindra R. S., Yuan J., Campisi D., Narayanan L., Jensen R., Giordano F., Johnson R. S., Rockwell S., Glazer P. M., Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Molecular and Cellular Biology 2003 23 9 3265 3273 2-s2.0-0037404420 10.1128/MCB.23.9.3265-3273.2003
77. Bindra R. S., Schaffer P. J., Meng A., Woo J., Måseide K., Roth M. E., Lizardi P., Hedley D. W., Bristow R. G., Glazer P. M., Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Molecular and Cellular Biology 2004 24 19 8504 8518 2-s2.0-4544324453 10.1128/MCB.24.19. 8504-8518.2004
78. Bindra R. S., Gibson S. L., Meng A., Westermark U., Jasin M., Pierce A. J., Bristow R. G., Classon M. K., Glazer P. M., Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Research 2005 65 24 11597 11604 2-s2.0-29244439933 10.1158/0008-5472.CAN-05-2119
79. Bindra R. S., Crosby M. E., Glazer P. M., Regulation of DNA repair in hypoxic cancer cells. Cancer and Metastasis Reviews 2007 26 2 249 260 2-s2.0-34547114718 10.1007/s10555-007-9061-3
80. Crosby M. E., Kulshreshtha R., Ivan M., Glazer P. M., MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Research 2009 69 3 1221 1229 2-s2.0-59149091637 10.1158/0008-5472.CAN-08-2516
81. Friboulet L., Barrios-Gonzales D., Commo F., Olaussen K. A., Vagner S., Adam J., Goubar A., Dorvault N., Lazar V., Job B., Besse B., Validire P., Girard P., Lacroix L., Hasmats J., Dufour F., André F., Soria J.-C., Molecular characteristics of ERCC1-negative versus ERCC1-positive tumors in resected NSCLC. Clinical Cancer Research 2011 17 17 5562 5572 2-s2.0-80052446021 10.1158/1078-0432.CCR-11-0790
82. Ding L., Xu Y., Zhang W., Deng Y., Si M., Du Y., Yao H., Liu X., Ke Y., Si J., Zhou T., MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Research 2010 20 7 784 793 2-s2.0-77955708471 10.1038/cr.2010.79
83. Liu A. M., Poon R. T., Luk J. M., MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochemical and Biophysical Research Communications 2010 394 3 623 627 2-s2.0-77950626836 10.1016/j.bbrc.2010.03.036
84. Xie Q.-H., He X.-X., Chang Y., Sun S.-Z., Jiang X., Li P.-Y., Lin J.-S., MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells. Biochemical and Biophysical Research Communications 2011 410 3 440 445 2-s2.0-79960034688 10.1016/j.bbrc.2011.05.153
85. Naccarati A., Pardini B., Landi S., Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk. Carcinogenesis 2012 33 7 1346 1351
86. Chaudhry M. A., Sachdeva H., Omaruddin R. A., Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways. DNA and Cell Biology 2010 29 9 553 561 2-s2.0-77956390556 10.1089/dna.2009.0978
87. Chiarugi V., Ruggiero M., Role of three cancer "master genes" p53, Bcl2 and c-myc on the apoptotic process. Tumori 1996 82 3 205 209 2-s2.0-0029900983
88. Papagiannakopoulos T., Shapiro A., Kosik K. S., MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Research 2008 68 19 8164 8172 2-s2.0-54249136806 10.1158/0008-5472.CAN-08-1305
89. Moskwa P., Buffa F. M., Pan Y., Panchakshari R., Gottipati P., Muschel R. J., Beech J., Kulshrestha R., Abdelmohsen K., Weinstock D. M., Gorospe M., Harris A. L., Helleday T., Chowdhury D., miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Molecular Cell 2011 41 2 210 220 2-s2.0-78651468714 10.1016/j.molcel.2010.12.005
90. Krishnan K., Steptoe A. L., Martin H. C., Wani S., Nones K., Waddell N., Mariasegaram M., Simpson P. T., Lakhani S. R., Gabrielli B., Vlassov A., Cloonan N., Grimmond S. M., MicroRNA-182-5p targets a network of genes involved in DNA repair. RNA 2013 19 2 230 242 10.1261/rna.034926.112
91. Rui W., Bing F., Hai-Zhu S., Wei D., Long-Bang C., Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). Journal of Cellular and Molecular Medicine 2010 14 1-2 206 214 2-s2.0-77951945516 10.1111/j.1582-4934.2009.00964.x
92. Teo M. T. W., Landi D., Taylor C. F., Elliott F., Vaslin L., Cox D. G., Hall J., Landi S., Bishop D. T., Kiltie A. E., The role of microrna-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis 2012 33 3 581 586 2-s2.0-84857926657 10.1093/carcin/bgr300
93. Yan M., Xu H., Waddell N., Shield K., Haviv I., Authors K., McKay M. J., Fox S. B., Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers. Breast Cancer Research 2012 14 2 R69 2-s2.0-84860138332 10.1186/bcr3176
94. Wang Y., Huang J. W., Calses P., Kemp C. J., Taniguchi T., MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Research 2012 72 16 4037 4046 10.1158/0008-5472.CAN-12- 0103
95. Zheng Z., Ng W. L., Zhang X., Olson J. J., Hao C., Curran W. J., Wang Y., RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells. Cancer Research 2012 72 5 1221 1228 2-s2.0-84857700087 10.1158/0008-5472.CAN-11-2785
96. Hegre S. A., Sætrom P., Aas P. A., Pettersen H. S., Otterlei M., Krokan H. E., Multiple microRNAs may regulate the DNA repair enzyme uracil-DNA glycosylase. DNA Repair 2013 12 1 80 86 10.1016/j.dnarep.2012.10.007
97. Jonker D. J., O'Callaghan C. J., Karapetis C. S., Zalcberg J. R., Tu D., Au H.-J., Berry S. R., Krahn M., Price T., Simes R. J., Tebbutt N. C., Van Hazel G., Wierzbicki R., Langer C., Moore M. J., Cetuximab for the treatment of colorectal cancer. The New England Journal of Medicine 2007 357 20 2040 2048 2-s2.0-36148941301 10.1056/NEJMoa071834
98. Ferrara N., Hillan K. J., Novotny W., Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochemical and Biophysical Research Communications 2005 333 2 328 335 2-s2.0-20544455330 10.1016/j.bbrc.2005.05.132
99. Hortobagyi G. N., Trastuzumab in the treatment of breast cancer. The New England Journal of Medicine 2005 353 16 1734 1736 2-s2.0-26844559765 10.1056/NEJMe058196
100. Haringhuizen A., van Tinteren H., Vaessen H. F. R., Baas P., van Zandwijk N., Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients. Annals of Oncology 2004 15 5 786 792 2-s2.0-2642561372 10.1093/annonc/mdh177
101. Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjärn M., Hansen H. F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E. M., Kauppinen S., LNA-mediated microRNA silencing in non-human primates. Nature 2008 452 7189 896 899 2-s2.0-42249093319 10.1038/nature06783
102. Kota J., Chivukula R. R., O'Donnell K. A., Wentzel E. A., Montgomery C. L., Hwang H.-W., Chang T.-C., Vivekanandan P., Torbenson M., Clark K. R., Mendell J. R., Mendell J. T., Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009 137 6 1005 1017 2-s2.0-66449136951 10.1016/j.cell.2009.04.021
103. Hatziapostolou M., Polytarchou C., Aggelidou E., Drakaki A., Poultsides G. A., Jaeger S. A., Ogata H., Karin M., Struhl K., Hadzopoulou-Cladaras M., Iliopoulos D., An HNF4 α -miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011 147 6 1233 1247 2-s2.0-83255162659 10.1016/j.cell.2011.10.043
104. Shu Y., Pi F., Sharma A., Rajabi M., Haque F., Shu D., Leggas M., Evers B. M., Guo P., Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Advanced Drug Delivery Reviews 2013 10.1016/j.addr.2013.11.006
105. Zhao L., Bode A. M., Cao Y., Dong Z., Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis 2012 33 11 2220 2227 10.1093/carcin/bgs235